Toshiyasu Mase

673 total citations
46 papers, 499 citations indexed

About

Toshiyasu Mase is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Toshiyasu Mase has authored 46 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 16 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Toshiyasu Mase's work include Synthesis and Reactions of Organic Compounds (7 papers), Receptor Mechanisms and Signaling (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Toshiyasu Mase is often cited by papers focused on Synthesis and Reactions of Organic Compounds (7 papers), Receptor Mechanisms and Signaling (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Toshiyasu Mase collaborates with scholars based in Japan, United Kingdom and Norway. Toshiyasu Mase's co-authors include K. Tomioka, Mark B. Swindells, Toshio Furuya, Jun Tanikawa, Toshiyuki Tanaka, Mitsuhiko Ikura, Masanori Osawa, Toshimitsu Yamada, Hideki Arima and Tadao Shibanuma and has published in prestigious journals such as Journal of Molecular Biology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Toshiyasu Mase

40 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiyasu Mase Japan 12 238 202 51 41 29 46 499
Masahiro Ohno Japan 15 282 1.2× 114 0.6× 54 1.1× 35 0.9× 49 1.7× 61 656
Kenji Kuromizu Japan 13 337 1.4× 123 0.6× 58 1.1× 41 1.0× 12 0.4× 29 436
Sally Rose United Kingdom 8 292 1.2× 93 0.5× 40 0.8× 50 1.2× 35 1.2× 12 510
James Z. Deng United States 15 289 1.2× 351 1.7× 88 1.7× 35 0.9× 19 0.7× 31 858
Daniéle Cantacuzène France 14 436 1.8× 326 1.6× 35 0.7× 16 0.4× 16 0.6× 24 657
Eric E. Boros United States 16 473 2.0× 283 1.4× 35 0.7× 27 0.7× 60 2.1× 36 840
Dennis A. Shuman United States 13 453 1.9× 194 1.0× 52 1.0× 26 0.6× 48 1.7× 18 623
Ryan MacArthur United States 16 307 1.3× 69 0.3× 64 1.3× 43 1.0× 40 1.4× 24 562
Youyi Peng United States 15 298 1.3× 271 1.3× 77 1.5× 105 2.6× 20 0.7× 28 685
Gilbert Diaz United States 13 326 1.4× 74 0.4× 66 1.3× 44 1.1× 22 0.8× 24 512

Countries citing papers authored by Toshiyasu Mase

Since Specialization
Citations

This map shows the geographic impact of Toshiyasu Mase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiyasu Mase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiyasu Mase more than expected).

Fields of papers citing papers by Toshiyasu Mase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiyasu Mase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiyasu Mase. The network helps show where Toshiyasu Mase may publish in the future.

Co-authorship network of co-authors of Toshiyasu Mase

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiyasu Mase. A scholar is included among the top collaborators of Toshiyasu Mase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiyasu Mase. Toshiyasu Mase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tanaka, Akihiro, et al.. (2004). A New Synthetic Route to YM087, an Arginine Vasopressin Antagonist. Heterocycles. 63(5). 1113–1113. 7 indexed citations
3.
Koutoku, Hiroshi, et al.. (2000). A Novel Class of Inhibitors for Human and Rat Steroid 5.ALPHA.-Reductases: Synthesis and Biological Evaluation of Indoline and Aniline Derivatives. III.. Chemical and Pharmaceutical Bulletin. 48(11). 1689–1697. 6 indexed citations
4.
Igarashi, S., et al.. (2000). A Novel Class of Inhibitors for Human Steroid 5.ALPHA.-Reductase: Synthesis and Biological Evaluation of Indole Derivatives. II.. Chemical and Pharmaceutical Bulletin. 48(3). 382–388. 5 indexed citations
5.
Suzuki, Takeshi, Hitoshi Nagaoka, Makoto Takeuchi, et al.. (1999). 2-(3-Pyridyl)thiazolidine-4-carboxamide Derivatives. III. Synthesis of Metabolites and Metabolism of 2-(3-Pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as Platelet-Activating Factor(PAF) Receptor Antagonists.. Chemical and Pharmaceutical Bulletin. 47(2). 165–170. 1 indexed citations
6.
Igarashi, S., et al.. (1999). A Novel Class of Inhibitors for Human Steroid 5.ALPHA.-Reductase. Phenoxybenzoic Acid Derivatives. I.. Chemical and Pharmaceutical Bulletin. 47(8). 1073–1080. 6 indexed citations
7.
Osawa, Masanori, Mark B. Swindells, Jun Tanikawa, et al.. (1998). Solution structure of Calmodulin-W-7 complex: the basis of diversity in molecular recognition. Journal of Molecular Biology. 276(1). 165–176. 132 indexed citations
9.
10.
Kontani, Toru, Fumikazu Wanibuchi, Hiroshi Yamashita, et al.. (1998). Synthesis and Pharmacological Characterization of Novel 6-Fluorochroman Derivatives as Potential 5-HT1A Receptor Antagonists. Journal of Medicinal Chemistry. 41(15). 2765–2778. 22 indexed citations
11.
12.
Kurihara, Hiroki, et al.. (1997). (−)-Formoterol, a Selective β2-Adrenoreceptor Agonist. Acta Crystallographica Section C Crystal Structure Communications. 53(12). 1887–1889.
13.
Matsuda, Koyo, Isao Yanagisawa, Y. ISOMURA, Toshiyasu Mase, & Tadao Shibanuma. (1997). Alternative Synthesis of Dibenzo-and Dipyrido-[1,3]Diazepines from Thioamides and o,o′-Diaminobiaryls. Synthetic Communications. 27(14). 2393–2402. 16 indexed citations
14.
Okamoto, Yoshinori, Hiroyuki Koshio, Mitsuaki Ohta, et al.. (1996). Biological Activity of Analogues of YM022. Novel (3-Amino Substituted Phenyl)urea Derivatives of 1,4-Benzodiazepin-2-one as Gastrin/Cholecystokinin-B Receptor Antagonists.. Chemical and Pharmaceutical Bulletin. 44(7). 1412–1414. 4 indexed citations
15.
Yamada, Toshimitsu, et al.. (1991). Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat. Biochemical and Biophysical Research Communications. 176(2). 781–785. 7 indexed citations
16.
Tomioka, K., et al.. (1989). Pharmacological Properties of YM-11124, a Selective Immunosuppressive Agent for Cell-Mediated Immunity. Pharmacology. 39(1). 28–38. 3 indexed citations
17.
Tomioka, K., et al.. (1987). Isolated tissue and binding studies of YM-17690, a novel and non-analogous leukotriene agonist. Journal of Pharmacy and Pharmacology. 39(10). 819–824. 3 indexed citations
18.
Mase, Toshiyasu & Kazuyuki Murase. (1984). ChemInform Abstract: Imidazo[2,1‐b]benzothiazole. Nucleophilic Substitution Reaction on Sulfur by n‐Butyl Lithium.. Chemischer Informationsdienst. 15(41). 1 indexed citations
20.
Mase, Toshiyasu, et al.. (1976). Unambiguous synthesis of 1-(7-indenyloxy)-3-isopropylamino-2-propanol hydrochloride and its 4-indenyloxy isomer, potent .BETA.-adrenergic blocking agents.. Chemical and Pharmaceutical Bulletin. 24(3). 552–554. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026